Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(1.45)

# 3,321

Out of 4,761 analysts

3

Total ratings

33.33%

Success rate

1.68%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dev Prasad

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVTX Avalo Therapeutics	Initiates: Buy	$24	$8.44	+184.36%	1	Dec 17, 2024
	IBIO iBio, Inc.	Initiates: Buy	$6	$3.48	+72.41%	1	Dec 17, 2024
	CALC CalciMedica	Initiates: Buy	$13	$2.35	+453.19%	1	Dec 17, 2024

Avalo Therapeutics

Dec 17, 2024

Initiates: Buy

Price Target: $24

Current: $8.44

Upside: +184.36%

iBio, Inc.

Dec 17, 2024

Initiates: Buy

Price Target: $6

Current: $3.48

Upside: +72.41%

CalciMedica

Dec 17, 2024

Initiates: Buy

Price Target: $13

Current: $2.35

Upside: +453.19%